http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02111722-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9fa13c33b79ba86e25d61d5e3cee4f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-665 |
| filingDate | 1989-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80aea6c3b115e811d31657c24e721912 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_082b7000f47e582f78b59c8f0fffe549 |
| publicationDate | 1990-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H02111722-A |
| titleOfInvention | Preventive and remedy for ischemic organopathy |
| abstract | PURPOSE: To obtain a preventive and remedy for ischemic organopathy useful for mammals including human, etc., showing inhibitory action on formation of peroxide lipid and reducing action on nest of myocardial infarction in ischemia/re-perfusion model, having extremely low toxicity, comprising a specific compound as an active ingredient. n CONSTITUTION: A preventive and remedy for ischemic organopathy containing a compound shown by the formula (R 1 to R 3 are H or CH 3 ) well-known as an anti-inflammatory drug, preventive and remedy for cataract and climaceric disorders or an agent for cosmetic having skin beautifying effects or a salt thereof such as sodium L-ascorbic acid DL-α-tocopherolphosphoric diester as an active ingredient. The active ingredient is blended with a carrier and an auxiliary, pharmaceutically manufactured into an oral drug such as tablet, capsule or syrup or parenteral drug such as injection and administered. A dose is generally ≥0.1mg/kg weight active ingredient for adult, usually 5-1,000mg/person/day and administered dividedly once-three times. n COPYRIGHT: (C)1990,JPO&Japio |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5965750-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6277834-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6046181-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0687411-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9939719-A1 |
| priorityDate | 1988-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453765139 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66586226 |
Total number of triples: 23.